Novas formas cristalinas do fármaco anti-HIV lamivudina com ácidos 1,2-dicarboxílicos: preparação, caracterização e solubilidade

Detalhes bibliográficos
Ano de defesa: 2014
Autor(a) principal: Silva, Cameron Capeletti da lattes
Orientador(a): Martins, Felipe Terra lattes
Banca de defesa: Sabino, Jose Ricardo lattes
Tipo de documento: Dissertação
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Universidade Federal de Goiás
Programa de Pós-Graduação: Programa de Pós-graduação em Química (IQ)
Departamento: Instituto de Química - IQ (RG)
País: Brasil
Palavras-chave em Português:
Palavras-chave em Inglês:
Área do conhecimento CNPq:
Link de acesso: http://repositorio.bc.ufg.br/tede/handle/tede/3107
Resumo: Co-crystallization of active pharmaceutical ingredients has been widely studied lately in order to improve the solid state features of such compounds, for example solubility, and also to protect the intellectual property of such compounds. Multicomponent molecular crystals can be prepared from both supramolecular synthon and screening approaches, which involve the variation of crystallization conditions. In this way, molecular crystal engineering is a strategy to improve solid state properties of drugs related to their efficacies. One branch of the lamivudine crystal engineering deals with its protonable pyrimidine-based nitrogen being a recipe of crystallization with carboxylic acids. Such strategy has yielded several pharmaceutical co-crystals and salts of APIs that have lamivudine-like heterocyclic nitrogens by choosing suitable carboxylic acids as a salt/co-crystal former. In this context and in relation to the drug antiretroviral nucleoside reverse transcriptase inhibitor lamivudine, four new crystalline phases thereof were prepared, their crystal structures were determined by X-ray diffraction by single crystal, and their solubility in water were measured. For the first time it was observed an in-plane pairing of lamivudine with the carboxylate and carboxyl functionalities of a same salt former unit giving rise to a trimer and a tetramer in the structures of lamivudine hydrogen phthalate hemihydrate and lamivudine hydrogen 4,5-dichlorophthalate, respectively. Besides, a new synthon have been found in the first salt. All lamivudine salts were less soluble than the lamivudine form II (free base). The unexpected heterosynthon can be related to the slightly higher solubility of lamivudine hydrogen 4,5-dichlorophthalate when compared to the other salts prepared in this study.
id UFG-2_fa2778b673fedfacbd6fe26f3d7ed06d
oai_identifier_str oai:repositorio.bc.ufg.br:tede/3107
network_acronym_str UFG-2
network_name_str Repositório Institucional da UFG
repository_id_str
spelling Martins, Felipe Terrahttp://lattes.cnpq.br/0466799995060671Sabino, Jose Ricardohttp://lattes.cnpq.br/9101677399031185http://lattes.cnpq.br/4581537476491370http://lattes.cnpq.br/2680476034460204Silva, Cameron Capeletti da2014-09-19T19:05:31Z2014-03-06Silva, Cameron Capeletti da. Novas formas cristalinas do fármaco anti-HIV lamivudina com ácidos 1,2-dicarboxílicos: preparação, caracterização e solubilidade. 2014. 85 f. Dissertação (Mestrado em Química) - Programa de Pós-graduação em Química (IQ) - Universidade Federal de Goiás, Goiânia.http://repositorio.bc.ufg.br/tede/handle/tede/3107Co-crystallization of active pharmaceutical ingredients has been widely studied lately in order to improve the solid state features of such compounds, for example solubility, and also to protect the intellectual property of such compounds. Multicomponent molecular crystals can be prepared from both supramolecular synthon and screening approaches, which involve the variation of crystallization conditions. In this way, molecular crystal engineering is a strategy to improve solid state properties of drugs related to their efficacies. One branch of the lamivudine crystal engineering deals with its protonable pyrimidine-based nitrogen being a recipe of crystallization with carboxylic acids. Such strategy has yielded several pharmaceutical co-crystals and salts of APIs that have lamivudine-like heterocyclic nitrogens by choosing suitable carboxylic acids as a salt/co-crystal former. In this context and in relation to the drug antiretroviral nucleoside reverse transcriptase inhibitor lamivudine, four new crystalline phases thereof were prepared, their crystal structures were determined by X-ray diffraction by single crystal, and their solubility in water were measured. For the first time it was observed an in-plane pairing of lamivudine with the carboxylate and carboxyl functionalities of a same salt former unit giving rise to a trimer and a tetramer in the structures of lamivudine hydrogen phthalate hemihydrate and lamivudine hydrogen 4,5-dichlorophthalate, respectively. Besides, a new synthon have been found in the first salt. All lamivudine salts were less soluble than the lamivudine form II (free base). The unexpected heterosynthon can be related to the slightly higher solubility of lamivudine hydrogen 4,5-dichlorophthalate when compared to the other salts prepared in this study.Co-cristalização de insumos farmacêuticos ativos tem sido largamente estudada ultimamente a fim de melhorar as propriedades do estado sólido, como, por exemplo, a solubilidade, e também manter a propriedade intelectual de tais compostos. Cristais moleculares multicomponentes podem ser preparados a partir da abordagem de sínton supramolecular e também através de métodos sistemáticos de investigação laboratorial, o que envolve a variação de condições de cristalização dos fármacos. Neste sentido, a engenharia de cristais moleculares é uma estratégia para aperfeiçoar as propriedades de estado sólido relacionadas às eficácias dos fármacos. Um ramo da engenharia de cristais de lamivudina lida com sua base nitrogenada pirimidina, a qual pode ser protonada, sendo assim um alvo de co-cristalização com ácidos carboxílicos. Tal estratégia tem rendido vários co-cristais e sais de insumos farmacêuticos ativos que possuem nitrogênio heterocíclico como a lamivudina pela escolha adequada de ácidos carboxílicos como um formador de sal/co-cristal. Nesse contexto, e com relação ao fármaco antirretroviral inibidor nucleosídeo de transcriptase reversa, a saber, lamivudina, quatro novas fases cristalinas foram preparadas, suas estruturas cristalinas foram elucidadas por difração de raios X por monocristal, e suas solubilidades em água foram aferidas. Nesse estudo, pela primeira vez foi observado um duplo pareamento da droga com ambas as funcionalidades ácidas do contra-íon originando uma tríade e um tetrâmero planar nas estruturas de biftalato de lamivudina hemidratado e 4,5-diclorohidrogenoftalado de lamivudina, respectivamente. Além disso, um novo sínton foi encontrado no primeiro sal. Todos eles foram menos solúvel do que a forma II da lamivudina (base livre). O inesperado heterosínton pôde ser correlacionado com a solubilidade ligeiramente maior do 4,5-diclorobiftalato de lamivudina quando comparado com os demais sais preparados.Fundação de Amparo à Pesquisa do Estado de Goiás - FAPEGapplication/pdfhttp://repositorio.bc.ufg.br/tede/retrieve/8079/Silva%2c%20Cameron-2014-disserta%c3%a7%c3%a3o.pdf.jpgporUniversidade Federal de GoiásPrograma de Pós-graduação em Química (IQ)UFGBrasilInstituto de Química - IQ (RG)http://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessSínton supramolecularEngenharia de cristaisLamivudinaSolubilidadeCrystal engineeringLamivudineSolubilitySupramolecular synthonFISICA DA MATERIA CONDENSADA::DINAMICA DA REDE E ESTATISTICA DE CRISTAISNovas formas cristalinas do fármaco anti-HIV lamivudina com ácidos 1,2-dicarboxílicos: preparação, caracterização e solubilidadeNew crystal forms of the anti-HIV drug lamivudine with 1,2-dicarboxilic acids: preparation, characterization and solubilityinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesis6636939213254151586006006006007826066743741197278530112412407533406-961409807440757778reponame:Repositório Institucional da UFGinstname:Universidade Federal de Goiás (UFG)instacron:UFGORIGINALSilva, Cameron-2014-dissertação.pdfSilva, Cameron-2014-dissertação.pdfapplication/pdf4685861http://repositorio.bc.ufg.br/tede/bitstreams/35b4ffbe-d1e3-44c2-9273-31717e57b3a2/download35a25c14813b0206d3d9c8fa6c8bfdafMD55LICENSElicense.txtlicense.txttext/plain; charset=utf-82165http://repositorio.bc.ufg.br/tede/bitstreams/6327fbd4-fb18-4520-985c-d53ee33a7f40/downloadbd3efa91386c1718a7f26a329fdcb468MD51CC-LICENSElicense_urllicense_urltext/plain; charset=utf-849http://repositorio.bc.ufg.br/tede/bitstreams/74c35edb-582f-421a-ad52-e6a3f1f71379/download4afdbb8c545fd630ea7db775da747b2fMD52license_textlicense_texttext/html; charset=utf-822302http://repositorio.bc.ufg.br/tede/bitstreams/d8906539-3cf2-4b8b-aea8-1c6eae1a48e7/download1e0094e9d8adcf16b18effef4ce7ed83MD53license_rdflicense_rdfapplication/rdf+xml; charset=utf-823148http://repositorio.bc.ufg.br/tede/bitstreams/9234d790-c107-433c-97d5-c9e4ef1880ad/download9da0b6dfac957114c6a7714714b86306MD54TEXTSilva, Cameron-2014-dissertação.pdf.txtSilva, Cameron-2014-dissertação.pdf.txtExtracted Texttext/plain146584http://repositorio.bc.ufg.br/tede/bitstreams/6819d964-311f-4b95-8571-058c7d124c07/download444bffe272806feba9f551c19e49a365MD56THUMBNAILSilva, Cameron-2014-dissertação.pdf.jpgSilva, Cameron-2014-dissertação.pdf.jpgGenerated Thumbnailimage/jpeg1943http://repositorio.bc.ufg.br/tede/bitstreams/2bae1935-e2b0-469b-bd83-90f1fe1b8e2c/downloadcc73c4c239a4c332d642ba1e7c7a9fb2MD57tede/31072025-01-24 07:14:41.123http://creativecommons.org/licenses/by-nc-nd/4.0/Acesso Abertoopen.accessoai:repositorio.bc.ufg.br:tede/3107http://repositorio.bc.ufg.br/tedeRepositório InstitucionalPUBhttps://repositorio.bc.ufg.br/tedeserver/oai/requestgrt.bc@ufg.bropendoar:oai:repositorio.bc.ufg.br:tede/12342025-01-24T10:14:41Repositório Institucional da UFG - Universidade Federal de Goiás (UFG)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
dc.title.por.fl_str_mv Novas formas cristalinas do fármaco anti-HIV lamivudina com ácidos 1,2-dicarboxílicos: preparação, caracterização e solubilidade
dc.title.alternative.por.fl_str_mv New crystal forms of the anti-HIV drug lamivudine with 1,2-dicarboxilic acids: preparation, characterization and solubility
title Novas formas cristalinas do fármaco anti-HIV lamivudina com ácidos 1,2-dicarboxílicos: preparação, caracterização e solubilidade
spellingShingle Novas formas cristalinas do fármaco anti-HIV lamivudina com ácidos 1,2-dicarboxílicos: preparação, caracterização e solubilidade
Silva, Cameron Capeletti da
Sínton supramolecular
Engenharia de cristais
Lamivudina
Solubilidade
Crystal engineering
Lamivudine
Solubility
Supramolecular synthon
FISICA DA MATERIA CONDENSADA::DINAMICA DA REDE E ESTATISTICA DE CRISTAIS
title_short Novas formas cristalinas do fármaco anti-HIV lamivudina com ácidos 1,2-dicarboxílicos: preparação, caracterização e solubilidade
title_full Novas formas cristalinas do fármaco anti-HIV lamivudina com ácidos 1,2-dicarboxílicos: preparação, caracterização e solubilidade
title_fullStr Novas formas cristalinas do fármaco anti-HIV lamivudina com ácidos 1,2-dicarboxílicos: preparação, caracterização e solubilidade
title_full_unstemmed Novas formas cristalinas do fármaco anti-HIV lamivudina com ácidos 1,2-dicarboxílicos: preparação, caracterização e solubilidade
title_sort Novas formas cristalinas do fármaco anti-HIV lamivudina com ácidos 1,2-dicarboxílicos: preparação, caracterização e solubilidade
author Silva, Cameron Capeletti da
author_facet Silva, Cameron Capeletti da
author_role author
dc.contributor.advisor1.fl_str_mv Martins, Felipe Terra
dc.contributor.advisor1Lattes.fl_str_mv http://lattes.cnpq.br/0466799995060671
dc.contributor.referee1.fl_str_mv Sabino, Jose Ricardo
dc.contributor.referee1Lattes.fl_str_mv http://lattes.cnpq.br/9101677399031185
dc.contributor.referee2Lattes.fl_str_mv http://lattes.cnpq.br/4581537476491370
dc.contributor.authorLattes.fl_str_mv http://lattes.cnpq.br/2680476034460204
dc.contributor.author.fl_str_mv Silva, Cameron Capeletti da
contributor_str_mv Martins, Felipe Terra
Sabino, Jose Ricardo
dc.subject.por.fl_str_mv Sínton supramolecular
Engenharia de cristais
Lamivudina
Solubilidade
topic Sínton supramolecular
Engenharia de cristais
Lamivudina
Solubilidade
Crystal engineering
Lamivudine
Solubility
Supramolecular synthon
FISICA DA MATERIA CONDENSADA::DINAMICA DA REDE E ESTATISTICA DE CRISTAIS
dc.subject.eng.fl_str_mv Crystal engineering
Lamivudine
Solubility
Supramolecular synthon
dc.subject.cnpq.fl_str_mv FISICA DA MATERIA CONDENSADA::DINAMICA DA REDE E ESTATISTICA DE CRISTAIS
description Co-crystallization of active pharmaceutical ingredients has been widely studied lately in order to improve the solid state features of such compounds, for example solubility, and also to protect the intellectual property of such compounds. Multicomponent molecular crystals can be prepared from both supramolecular synthon and screening approaches, which involve the variation of crystallization conditions. In this way, molecular crystal engineering is a strategy to improve solid state properties of drugs related to their efficacies. One branch of the lamivudine crystal engineering deals with its protonable pyrimidine-based nitrogen being a recipe of crystallization with carboxylic acids. Such strategy has yielded several pharmaceutical co-crystals and salts of APIs that have lamivudine-like heterocyclic nitrogens by choosing suitable carboxylic acids as a salt/co-crystal former. In this context and in relation to the drug antiretroviral nucleoside reverse transcriptase inhibitor lamivudine, four new crystalline phases thereof were prepared, their crystal structures were determined by X-ray diffraction by single crystal, and their solubility in water were measured. For the first time it was observed an in-plane pairing of lamivudine with the carboxylate and carboxyl functionalities of a same salt former unit giving rise to a trimer and a tetramer in the structures of lamivudine hydrogen phthalate hemihydrate and lamivudine hydrogen 4,5-dichlorophthalate, respectively. Besides, a new synthon have been found in the first salt. All lamivudine salts were less soluble than the lamivudine form II (free base). The unexpected heterosynthon can be related to the slightly higher solubility of lamivudine hydrogen 4,5-dichlorophthalate when compared to the other salts prepared in this study.
publishDate 2014
dc.date.accessioned.fl_str_mv 2014-09-19T19:05:31Z
dc.date.issued.fl_str_mv 2014-03-06
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.citation.fl_str_mv Silva, Cameron Capeletti da. Novas formas cristalinas do fármaco anti-HIV lamivudina com ácidos 1,2-dicarboxílicos: preparação, caracterização e solubilidade. 2014. 85 f. Dissertação (Mestrado em Química) - Programa de Pós-graduação em Química (IQ) - Universidade Federal de Goiás, Goiânia.
dc.identifier.uri.fl_str_mv http://repositorio.bc.ufg.br/tede/handle/tede/3107
identifier_str_mv Silva, Cameron Capeletti da. Novas formas cristalinas do fármaco anti-HIV lamivudina com ácidos 1,2-dicarboxílicos: preparação, caracterização e solubilidade. 2014. 85 f. Dissertação (Mestrado em Química) - Programa de Pós-graduação em Química (IQ) - Universidade Federal de Goiás, Goiânia.
url http://repositorio.bc.ufg.br/tede/handle/tede/3107
dc.language.iso.fl_str_mv por
language por
dc.relation.program.fl_str_mv 663693921325415158
dc.relation.confidence.fl_str_mv 600
600
600
600
dc.relation.department.fl_str_mv 7826066743741197278
dc.relation.cnpq.fl_str_mv 530112412407533406
dc.relation.sponsorship.fl_str_mv -961409807440757778
dc.rights.driver.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Goiás
dc.publisher.program.fl_str_mv Programa de Pós-graduação em Química (IQ)
dc.publisher.initials.fl_str_mv UFG
dc.publisher.country.fl_str_mv Brasil
dc.publisher.department.fl_str_mv Instituto de Química - IQ (RG)
publisher.none.fl_str_mv Universidade Federal de Goiás
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFG
instname:Universidade Federal de Goiás (UFG)
instacron:UFG
instname_str Universidade Federal de Goiás (UFG)
instacron_str UFG
institution UFG
reponame_str Repositório Institucional da UFG
collection Repositório Institucional da UFG
bitstream.url.fl_str_mv http://repositorio.bc.ufg.br/tede/bitstreams/35b4ffbe-d1e3-44c2-9273-31717e57b3a2/download
http://repositorio.bc.ufg.br/tede/bitstreams/6327fbd4-fb18-4520-985c-d53ee33a7f40/download
http://repositorio.bc.ufg.br/tede/bitstreams/74c35edb-582f-421a-ad52-e6a3f1f71379/download
http://repositorio.bc.ufg.br/tede/bitstreams/d8906539-3cf2-4b8b-aea8-1c6eae1a48e7/download
http://repositorio.bc.ufg.br/tede/bitstreams/9234d790-c107-433c-97d5-c9e4ef1880ad/download
http://repositorio.bc.ufg.br/tede/bitstreams/6819d964-311f-4b95-8571-058c7d124c07/download
http://repositorio.bc.ufg.br/tede/bitstreams/2bae1935-e2b0-469b-bd83-90f1fe1b8e2c/download
bitstream.checksum.fl_str_mv 35a25c14813b0206d3d9c8fa6c8bfdaf
bd3efa91386c1718a7f26a329fdcb468
4afdbb8c545fd630ea7db775da747b2f
1e0094e9d8adcf16b18effef4ce7ed83
9da0b6dfac957114c6a7714714b86306
444bffe272806feba9f551c19e49a365
cc73c4c239a4c332d642ba1e7c7a9fb2
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFG - Universidade Federal de Goiás (UFG)
repository.mail.fl_str_mv grt.bc@ufg.br
_version_ 1861293887750930432